Literature DB >> 17061022

ADAM33 polymorphisms are associated with aspirin-intolerant asthma in the Japanese population.

Takuro Sakagami1,2, Nobuyoshi Jinnai3, Toshiaki Nakajima3, Takashi Sekigawa4,3, Takashi Hasegawa5, Eiichi Suzuki5, Ituro Inoue3, Fumitake Gejyo4.   

Abstract

Multiple single nucleotide polymorphisms (SNPs) within ADAM33 have been reported to be associated with asthma and bronchial hyper-responsiveness in Caucasian populations. We examined whether these SNPs contribute to a predisposition to asthma, especially aspirin-intolerant asthma (AIA), in the Japanese population. Ten polymorphic sites (ST+4, ST+7, T1, T2, T+1, V-3, V-2, V-1, V4, V5) were genotyped in 102 AIA patients, 282 aspirin-tolerant asthma (ATA) patients and 120 control (CTR) subjects by direct sequencing. Haplotype frequencies were estimated by the expectation-maximization method. Differences in allele and haplotype frequencies among phenotypes were analyzed by the chi-square and permutation tests. ST+7, V-1 and V5 sites in the AIA group were significantly different from those in the ATA group (P=0.034-0.004) and from those in the CTR group (P=0.019-0.002). Haplotypes at three sites (ST+7, V-1, and V5) were significantly different in frequency between the AIA and ATA (P=0.008) or CTR (P=0.001) groups. Sequence variations in ADAM33 are likely to correlate with susceptibility to AIA in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17061022     DOI: 10.1007/s10038-006-0081-6

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  32 in total

1.  Model-free analysis and permutation tests for allelic associations.

Authors:  J H Zhao; D Curtis; P C Sham
Journal:  Hum Hered       Date:  2000 Mar-Apr       Impact factor: 0.444

2.  Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity.

Authors:  Tsuyoshi Yoshinaka; Kazuhiro Nishii; Kouji Yamada; Hirohide Sawada; Eiji Nishiwaki; Katherine Smith; Kohichiro Yoshino; Hiroshi Ishiguro; Shigeki Higashiyama
Journal:  Gene       Date:  2002-01-09       Impact factor: 3.688

3.  ADAM33 is not associated with asthma in Puerto Rican or Mexican populations.

Authors:  Denise L Lind; Shweta Choudhry; Ngim Ung; Elad Ziv; Pedro C Avila; Keyan Salari; Connie Ha; Elizabeth G Lovins; Natasha E Coyle; Sylvette Nazario; Jesus Casal; Alfonso Torres; Jose R Rodriguez-Santana; Henry Matallana; Craig M Lilly; Jorge Salas; Moises Selman; Homer A Boushey; Scott T Weiss; Rocio Chapela; Jean G Ford; William Rodriguez-Cintron; Edwin K Silverman; Dean Sheppard; Pui-Yan Kwok; Esteban González Burchard
Journal:  Am J Respir Crit Care Med       Date:  2003-09-04       Impact factor: 21.405

4.  The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models.

Authors:  R C Lewontin
Journal:  Genetics       Date:  1964-01       Impact factor: 4.562

Review 5.  Guidelines for the diagnosis and management of bronchial asthma. Committee on the Definition, Treatment, and Management of Bronchial Asthma. Japanese Society of Allergology.

Authors: 
Journal:  Allergy       Date:  1995       Impact factor: 13.146

6.  Association between ADAM33 polymorphisms and adult asthma in the Japanese population.

Authors:  T Hirota; K Hasegawa; K Obara; A Matsuda; M Akahoshi; K Nakashima; T Shirakawa; S Doi; K Fujita; Y Suzuki; Y Nakamura; M Tamari
Journal:  Clin Exp Allergy       Date:  2006-07       Impact factor: 5.018

7.  Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.

Authors:  Masanori Asakura; Masafumi Kitakaze; Seiji Takashima; Yulin Liao; Fuminobu Ishikura; Tsuyoshi Yoshinaka; Hiroshi Ohmoto; Koichi Node; Kohichiro Yoshino; Hiroshi Ishiguro; Hiroshi Asanuma; Shoji Sanada; Yasushi Matsumura; Hiroshi Takeda; Shintaro Beppu; Michihiko Tada; Masatsugu Hori; Shigeki Higashiyama
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

8.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).

Authors:  K J Garton; P J Gough; C P Blobel; G Murphy; D R Greaves; P J Dempsey; E W Raines
Journal:  J Biol Chem       Date:  2001-08-08       Impact factor: 5.157

9.  5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States.

Authors:  R Van Sambeek; D D Stevenson; M Baldasaro; B K Lam; J Zhao; S Yoshida; C Yandora; J M Drazen; J F Penrose
Journal:  J Allergy Clin Immunol       Date:  2000-07       Impact factor: 10.793

10.  Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach.

Authors:  Nobuyoshi Jinnai; Takuro Sakagami; Takashi Sekigawa; Miho Kakihara; Toshiaki Nakajima; Kenichi Yoshida; Shin Goto; Takashi Hasegawa; Takeshi Koshino; Yoshinori Hasegawa; Hiromasa Inoue; Naohito Suzuki; Yasuyuki Sano; Ituro Inoue
Journal:  Hum Mol Genet       Date:  2004-10-20       Impact factor: 6.150

View more
  14 in total

1.  Association of ADAM33 gene with susceptibility to COPD in Tibetan population of China.

Authors:  Jinling Xiao; Jianyu Han; Xinyan Wang; Demi Hua; Dongju Su; Yongxia Bao; Fuzhen Lv
Journal:  Mol Biol Rep       Date:  2010-12-15       Impact factor: 2.316

2.  Association of ADAM33 gene polymorphisms with adult-onset asthma and its severity in an Indian adult population.

Authors:  Priya Tripathi; Shally Awasthi; Rajendra Prasad; Nuzhat Husain; Subramaniam Ganesh
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

3.  Association of IL-4 and ADAM33 gene polymorphisms with asthma in an Indian population.

Authors:  Mahdi Bijanzadeh; Nallur B Ramachandra; P A Mahesh; R Savitha Mysore; Pradeep Kumar; B S Manjunath; B S Jayaraj
Journal:  Lung       Date:  2010-06-04       Impact factor: 2.584

4.  Association of a disintegrin and metalloprotease 33 gene polymorphisms with asthma.

Authors:  Nigela Yilihamu; Qimangul Wushouer; Kadirya Arkin; Hu Xin; Umesh Yadav
Journal:  Mol Clin Oncol       Date:  2014-07-09

5.  A possible association of EMID2 polymorphisms with aspirin hypersensitivity in asthma.

Authors:  Charisse Flerida A Pasaje; Jeong-Hyun Kim; Byung-Lae Park; Hyun Sub Cheong; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Chein-Soo Hong; Yong Won Lee; Jae-Young Lee; In Song Koh; Tae-Joon Park; Jin-Sol Lee; Yongha Kim; Joon Seol Bae; Choon-Sik Park; Hyoung Doo Shin
Journal:  Immunogenetics       Date:  2010-11-18       Impact factor: 2.846

6.  ADAM33 gene polymorphisms identified to be associated with asthma in a Chinese Li population.

Authors:  Bo Shen; Rong Lin; Cai-Chun Wang; Jing Rei; Yan Sun; Yong-Le Yang; Ying-Ying Lin
Journal:  Biomed Rep       Date:  2017-02-08

7.  Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case study.

Authors:  Jason Yongha Kim; Jeong Hyun Kim; Tae Joon Park; Joon Seol Bae; Jin Sol Lee; Charisse Flerida Pasaje; Byung Lae Park; Hyun Sub Cheong; Jong-Sook Park; Sung-Woo Park; Soo-Taek Uh; Mi-Kyeong Kim; Inseon S Choi; Sang Heon Cho; Byoung Whui Choi; Choon-Sik Park; Hyoung Doo Shin
Journal:  BMC Pulm Med       Date:  2010-06-01       Impact factor: 3.317

8.  Association of ADAM33 gene polymorphisms with adult concomitant allergic rhinitis and asthma in Chinese Han population.

Authors:  Ximei Zhang; Dongju Su; Xuelong Zhang; Hong Sui; Lianhong Jin; Fuzhen Lü; Jing Zhang
Journal:  Mol Biol Rep       Date:  2008-08-28       Impact factor: 2.316

Review 9.  Role of ADAM and ADAMTS metalloproteinases in airway diseases.

Authors:  Genevieve Paulissen; Natacha Rocks; Maud M Gueders; Celine Crahay; Florence Quesada-Calvo; Sandrine Bekaert; Jonathan Hacha; Mehdi El Hour; Jean-Michel Foidart; Agnes Noel; Didier D Cataldo
Journal:  Respir Res       Date:  2009-12-24

10.  Association of ADAM33 gene polymorphisms with adult allergic asthma and rhinitis in a Chinese Han population.

Authors:  Dongju Su; Ximei Zhang; Hong Sui; Fuzhen Lü; Lianhong Jin; Jing Zhang
Journal:  BMC Med Genet       Date:  2008-09-09       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.